Source usp certified cyproheptadine powder for sleep aid, appetite, and allergy relief

Strategic Sourcing Guide for USP Certified Cyproheptadine Powder

Procuring high-purity active pharmaceutical ingredients (APIs) requires a disciplined approach that balances technical verification with supply chain reliability. When the core search term focuses on USP certified cyproheptadine powder, buyers must navigate a landscape where specific chemical identifiers, regulatory compliance, and physical attributes converge. The following guide outlines the critical dimensions of sourcing this specific compound, relying on observed market data and established pharmaceutical standards to inform decision-making without extrapolating unverified claims.

Technical Specifications and Chemical Identity

The foundation of any successful procurement begins with the precise identification of the chemical entity. Cyproheptadine Hydrochloride is the specific salt form often referenced in pharmaceutical contexts, distinguished from the base compound by its hydrochloride salt structure. Market observations indicate that the molecular formula for the hydrochloride variant is frequently cited as C21H22ClN, while the base form is associated with C21H21N. Buyers must rigorously verify the CAS registry number to ensure the correct salt form is being sourced. The CAS number 41354-29-4 is the definitive identifier for Cyproheptadine Hydrochloride, whereas 129-03-3 corresponds to the base form. Confusing these two can lead to significant formulation errors.

Physical properties are equally critical for processing and storage. The product is consistently observed as a white to off-white powder in its solid state. Specific gravity and density estimates for the base form suggest a value around 0.9917 g/cm³, though this should be confirmed via the Certificate of Analysis (COA) for the specific batch. The melting point is a key purity indicator, with observed ranges typically falling between 112.3°C and 113.3°C for the base compound. Solubility characteristics are also vital; water solubility is noted at approximately 317.6 µg/L at 22.5°C, indicating that the compound requires specific solvents or formulation techniques for dissolution in aqueous environments.

Storage requirements are non-negotiable for maintaining integrity. The product must be stored in a cool and dry place to prevent degradation. Packaging often utilizes aluminum foil bags or paper drums to ensure protection from moisture and light. For bulk orders, the standard packing configuration may involve 1kg foil bags nested within 25kg drums, or vacuum-sealed foil bags for smaller quantities. These packaging standards are designed to maintain the stability of the powder over its shelf life, which is typically observed to be two years under proper conditions.

Compliance and Certification Verification

In the pharmaceutical supply chain, certification is not merely a marketing label but a prerequisite for regulatory compliance. The core keyword "USP certified" implies adherence to the United States Pharmacopeia standards, which govern the quality, purity, and strength of drug substances. Market data confirms that suppliers often list certifications including USP, BP (British Pharmacopoeia), and ISO GMP (Good Manufacturing Practice). Some listings also reference ISO HSE (Health, Safety, and Environment) standards, indicating a broader commitment to operational safety.

Buyers must distinguish between a supplier's claim of certification and the actual availability of a valid COA. The presence of a USP standard in the product description suggests that the material meets the monograph requirements for Cyproheptadine Hydrochloride. However, the buyer's responsibility is to verify that the specific batch being purchased is accompanied by a COA that explicitly references the USP monograph. The assay method for verifying purity is typically High-Performance Liquid Chromatography (HPLC), with observed purity levels often stated as greater than 99%.

It is important to note that while ISO 9001:2015 is a recognized quality management standard, it is a general framework and does not replace the specific pharmacopeial standards required for APIs. Therefore, a supplier may hold ISO 9001 certification, but the critical verification for Cyproheptadine remains the USP or BP compliance. Buyers should request documentation proving that the manufacturing facility operates under GMP conditions, as this ensures that the production process is controlled and consistent. The "Pharmaceutical Grade" designation is a common attribute observed in listings, but it must be backed by the specific test results found in the COA.

Cost Drivers and Economic Factors

The pricing of Cyproheptadine powder is influenced by several variables, including purity levels, packaging formats, and the scale of the order. Observed market data indicates a wide price range, spanning from $0.07 to $200 per unit, though this variance is heavily dependent on the unit of measure and the specific product configuration. A unit price of $0.07 likely refers to a bulk kilogram or larger industrial lot, whereas higher figures may reflect smaller, specialized packaging or premium certification tiers.

Minimum Order Quantity (MOQ) is a significant cost driver. The market shows an MOQ range from 1 gram to 50,000 grams. For research or small-scale clinical trials, an MOQ of 10 grams or 1 kilogram may be available, allowing for lower upfront capital expenditure. However, larger commercial orders often require a commitment of 1 kilogram or more to access competitive pricing. The "Customized" attribute observed in listings suggests that suppliers may offer tailored packaging or labeling, which can introduce additional costs.

Currency fluctuations and raw material availability also impact the final landed cost. Since the primary origin for these products is China, buyers must consider logistics costs, import duties, and potential supply chain disruptions. The "Customized" nature of the product means that specific requests for packaging or documentation may incur extra fees. Buyers should negotiate based on the total cost of ownership, including shipping and insurance, rather than focusing solely on the per-unit price.

Typical Applications and Formulation Considerations

Cyproheptadine Hydrochloride is primarily utilized in the pharmaceutical industry as an antihistamine and appetite stimulant. Its application extends to the treatment of allergic reactions and the management of conditions requiring appetite enhancement. The "Suitable for" attribute indicates that the product is intended for use in formulations for adults, children, and the elderly, though dosage adjustments are necessary based on the target demographic.

In formulation, the powder's physical state as a solid and its solubility profile dictate the manufacturing process. The low water solubility requires careful selection of excipients to ensure bioavailability. The "Application" field often lists "Pharmaceutical Intermediate," suggesting that the powder may be used as a starting material for further synthesis or as a direct API in tablet or capsule formulations. The "Function" as a sleep aid is also noted in some contexts, highlighting its sedative properties which are a result of its antihistaminic activity.

Buyers must ensure that the intended application aligns with the regulatory status of the product in their target market. While the product is suitable for various age groups, the final formulation must comply with local regulatory requirements regarding pediatric and geriatric use. The "Specific" attribute, often referring to the provision of a COA, is essential for validating the product for specific therapeutic uses.

Supplier Evaluation and Quality Assurance

Evaluating a supplier for Cyproheptadine powder requires a multi-faceted approach. The presence of certifications like USP, BP, and ISO GMP is a strong initial indicator, but it must be verified through direct communication and document review. Buyers should request a sample batch to perform independent testing, focusing on the assay method (HPLC) and purity (>99%). The "Test Method" should be clearly defined in the supplier's documentation.

The "Appearance" of the powder, described as white or off-white, is a visual quality check that should be consistent with the COA. Any deviation in color or texture could indicate contamination or degradation. The "Shelf Life" of two years is a standard benchmark, but buyers should verify the expiration date on the specific batch they receive. Packaging integrity is also a critical factor; the use of aluminum foil bags and vacuum sealing helps maintain the product's stability.

When comparing suppliers, a structured evaluation matrix can be useful. The following table summarizes key attributes to compare across potential vendors:

This comparison highlights that while core specifications may be similar, the MOQ and packaging options can vary significantly, influencing the procurement strategy.

Long-Term Procurement Considerations

Sourcing Cyproheptadine powder is not a one-time transaction but a long-term relationship that requires ongoing quality management. The "Customization" capability of suppliers is a valuable asset for buyers with specific needs, such as custom labeling or unique packaging requirements. However, customization should be balanced against the risk of supply chain complexity.

Buyers should establish a robust quality agreement with their supplier that defines acceptance criteria, testing protocols, and change management procedures. Regular audits of the manufacturing facility, if feasible, can provide additional assurance of compliance. The "Specific" requirement for a COA should be a non-negotiable condition of every shipment.

As the market evolves, buyers must remain vigilant about changes in regulatory standards. The USP monograph may be updated, and suppliers must demonstrate their ability to adapt to these changes. The "Standard" of 99% is a common benchmark, but buyers should be prepared for the possibility of stricter requirements in the future. Maintaining a diversified supplier base can mitigate the risk of supply disruptions and ensure continuity of operations.

In conclusion, sourcing USP certified Cyproheptadine powder demands a rigorous approach to technical verification, compliance checks, and supplier evaluation. By focusing on the specific chemical identifiers, certification documentation, and quality assurance protocols, buyers can secure a reliable supply of high-quality material for their pharmaceutical needs. The observed data provides a solid foundation for decision-making, but the ultimate success of the procurement lies in the buyer's ability to validate these facts through direct engagement and independent testing.